Skip to content

Health status guided COPD Care (MARCH).

Health status guided COPD Care (MARCH).

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20748
Enrollment
330
Registered
2010-12-07
Start date
2008-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Health Related Quality of Life

Interventions

Control treatment: Standard COPD Treatment according the NHG guidelines. Experimental treatment: Standardized health status measurement by the CCQ followed by treatment advice given to the general

Sponsors

University Medical Center Groningen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of COPD; 2. Aged 40 yrs; 3. Smoking history: 10 pack-yrs; 4. FEV1/ forced vital capacity (FVC) <0.70 post bronchodilator.

Exclusion criteria

Exclusion criteria: 1. Myocardial infarction less than 3 months ago; 2. Inability to read and understand the Dutch language; 3. History of asthma or allergic rhinitis before the age of 40; 4. Regular use of oxygen; 5. Unstable or life-threatening comorbid condition (as judged by the investigator); 6. Dementia.

Design outcomes

Primary

MeasureTime frame
Change in SGRQ over time. Because the intervention is guided by the CCQ, a different health status instrument, the SGRQ, will be used as an outcome measure. In the treatment of COPD patients in primary care, the improvement of health status and reduction of exacerbations are the main goals of treatment. In this perspective it is a logical choice to use a health status questionnaire to guide treatment. The second primary outcome will be the exacerbation frequency, measured by medication use. This is one of the classical COPD outcomes and exacerbations have a large impact on patients’ lives.

Secondary

MeasureTime frame
1. Change in CCQ score; 2. Changes in 6 minute walking distance test results; 3. Changes in HADS and mMRC; 4. Hospital admissions; 5. Death; 6. Changes in lung function.

Contacts

Public ContactC. Jong, de

P.O.Box 30.001

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)